Psychedelics.media is a global B2B media platform covering psychedelic medicine, biotech, policy, research, and industry developments.For general enquiries, partnerships, interviews, or collaboration requests, please use the form and we’ll get back to you as soon as possible.
For press releases and news submissions, please email:
contact@psychedelics.media
We review all relevant submissions, but prioritise news relating to publicly listed companies, clinical research, regulatory updates, and industry developments.
© 2026 Psychedelics.media - A division of Dot Media Corp.
© 2026 Psychedelics.media - A division of Dot Media Corp.